JP Patent

JP6930913B2 — 炎症を阻害するためのｃｄｋ９及びｂｒｄ４阻害剤の使用法

Assigned to University of California · Expires 2021-09-01 · 5y expired

What this patent protects

Patent listed against pacritinib-citrate.

Drugs covered by this patent

pacritinib-citrate (PACRITINIB CITRATE)

Patent Metadata

Patent number: JP6930913B2
Jurisdiction: JP
Classification: —
Expires: 2021-09-01
Drug substance claim: No
Drug product claim: No
Assignee: University of California
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.